MYCN and neuroblastoma: In neuroblastomas with MYCN amplification, this oncogene stabilizes the adrenergic CRC to drive the expression of its transcriptional regulatory network and enforce an immature neuroblast cell state while suppressing developmental signals that would normally induce differentiation or senescence (17).